Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalab
| Current Price | ₹635.20 |
|---|---|
| Market Cap | ₹5,759 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 33 |
| Return on Equity | 8.49% |
| 52-Week Range | ₹585.00 – ₹971.00 |
| Beta (1Y) | 0.52 |
| Dividend Yield | 0.63% |
1. Pharmeceuticals-100%
Aarti Pharmalabs Ltd is trading at ₹635.20, with a market capitalisation of ₹5,759 Cr.
Aarti Pharmalabs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space.
Aarti Pharmalabs Ltd has a P/E of 33 and a return on equity of 8.49%.